The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Statistics Notes: Detecting skewness from summary information: Table 1
Open accessAbstract
The measurement of airway resistance by the interrupter technique (Rint) needs standardization. Should measurements be made be during the expiratory or inspiratory phase of tidal breathing? In reported studies, the measurement of Rint has been calculated as the median or mean of a small number of values, is there an important difference? Subjects were 2.5–5.0 yrs (median 4.0 yrs) who had previous respiratory symptoms. The Rint in expiration (RintE) and inspiration (RintI) pre and postsalbutamol, the coefficient of variation (CV) of values contributing to measurements, and bronchodilator responsiveness (BDR) in both phases were compared. Measurements using median and mean were compared. RintE was higher than RintI by 4% (p<0.01). The CV of values making up RintE and RintI, and BDR measured in expiration and inspiration were similar. The median difference between means and medians of values making up measurements was 0.6% (range −6–11%). RintE has been shown to be consistently greater then RintI but the difference in this study is small. It is suggested that one or the other is chosen as the standard. In the present data the mean of a set of values contributing to a measurement was not significantly different from the median. However, the use of the median has been recommended since it is less affected by possible outlying values such as might be included by fully automated equipment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“when a scale starts from the finite number zero, the standard deviation, when multiplied by two, is less than the mean (as otherwise the mean is unlikely to be an appropriate measure of the centre of the distribution (Altman 1996)”
From Compulsory community and involuntary outpatient treatment for people with severe mental disorders. (2017) · cites this paper as Altman 1996
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistics notes: The normal distribution
Altman, D. G., & Bland, J. M. (1995) · BMJ · doi:10.1136/bmj.310.6975.298 · Cited by 549
Statistics Notes: Transforming data
Bland, J. M., & Altman, D. G. (1996) · BMJ · doi:10.1136/bmj.312.7033.770 · Cited by 297
Statistics Notes: Quartiles, quintiles, centiles, and other quantiles
Altman, D. G., & Bland, M. (1994) · BMJ · doi:10.1136/bmj.309.6960.996 · Cited by 181
Effects of Environmental Tobacco Smoke on Urinary Cotinine Excretion in Nonsmokers
Matsukura, S., Taminato, T., Kitano, N., Seino, Y., HAMADA, H., Uchihashi, M., Nakajima, H., & Hirata, Y. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111305 · Cited by 177
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 1,000
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis
Filippini, G., Giovane, C. D., Vacchi, L., D’Amico, R., Pietrantonj, C. D., Beecher, D., & Salanti, G. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008933.pub2 · Cited by 191
Clinical interventions for treatment non-adherence in psychosis: Meta-analysis
Nosè, M., Barbui, C., Gray, R. J., & Tansella, M. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.183.3.197 · Cited by 185
Supported employment for adults with severe mental illness
Kinoshita, Y., Furukawa, T. A., Kinoshita, K., Honyashiki, M., Omori, I. M., Marshall, M., Bond, G. R., Huxley, P., Amano, N., & Kingdon, D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008297.pub2 · Cited by 182
Antidepressants for the treatment of depression in people with cancer
Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., & Hotopf, M. H. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub2 · Cited by 184
Sertindole versus other atypical antipsychotics for schizophrenia
Komossa, K., Rummel‐Kluge, C., Hunger, H., Schwarz, S., Schmid, F., Lewis, R. A., Kissling, W., & Leucht, S. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006752.pub2 · Cited by 183
Risperidone versus typical antipsychotic medication for schizophrenia
Hunter, R., Kennedy, E., Song, F., Gadon, L., & Irving, C. B. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000440 · Cited by 182
Barbui, C., & Hotopf, M. H. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.2.129 · Cited by 183
Music therapy for people with schizophrenia and schizophrenia-like disorders
Mössler, K. A., Chen, X., Heldal, T. O., & Gold, C. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004025.pub3 · Cited by 188
Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders
David, A. S., Adams, C. E., & Quraishi, S. N. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001470 · Cited by 182
Pharmacological treatment of cocaine dependence: a systematic review
de Lima, M. S., Soares, B. G. D. O., Reisser, A. A. L., & Farrell, M. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00209.x · Cited by 178
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation)
Ostinelli, E. G., Powney, M. J., Li, X., & Adams, C. E. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009377.pub3 · Cited by 182
Sulpiride versus placebo for schizophrenia
Omori, I. M., & Wang, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007811 · Cited by 173
Leucht, S., Helfer, B., Dold, M., Kissling, W., & McGrath, J. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003834.pub3 · Cited by 173
Cognitive Behavior Therapy Versus Other Psychosocial Treatments for Schizophrenia
Jones, C., Hacker, D., Cormac, I., Meaden, A., & Irving, C. B. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs090 · Cited by 172
Maintenance treatment with antipsychotic drugs for schizophrenia
Ceraso, A., Lin, J., Schneider‐Thoma, J., Siafis, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Davis, J. M., & Leucht, S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008016.pub3 · Cited by 184
Intercessory prayer for the alleviation of ill health
Roberts, L., Ahmed, I., & Davison, A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000368.pub3 · Cited by 173
Chlorpromazine versus placebo for schizophrenia
Adams, C. E., Awad, G. A., Rathbone, J., Thornley, B., & Soares‐Weiser, K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000284.pub3 · Cited by 167
Second-generation antipsychotics for major depressive disorder and dysthymia
Komossa, K., Depping, A. M., Gaudchau, A., Kissling, W., & Leucht, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008121.pub2 · Cited by 173
Benzodiazepines for schizophrenia
Dold, M., Li, C., Tardy, M., Khorsand, V., Gillies, D. M., & Leucht, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006391.pub2 · Cited by 169
Duloxetine versus other anti-depressive agents for depression
Cipriani, A., Koesters, M., Furukawa, T. A., Nosè, M., Purgato, M., Omori, I. M., Trespidi, C., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006533.pub2 · Cited by 172
Depot perphenazine decanoate and enanthate for schizophrenia
David, A. S., & Quraishi, S. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001717 · Cited by 164
Morris, S., Bagnall, A., Cooper, S. J., DeSilva, P., Fenton, M., Gammelin, G., & Leitner, M. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001948 · Cited by 164
Ketamine and other glutamate receptor modulators for depression in adults
Caddy, C., Amit, B. H., McCloud, T. L., Rendell, J. M., Furukawa, T. A., McShane, R., Hawton, K., & Cipriani, A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011612.pub2 · Cited by 174
Depot pipothiazine palmitate and undecylenate for schizophrenia
David, A. S., & Quraishi, S. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001720 · Cited by 163
Murphy, B. M., Bagnall, A., Chue, P. S., Fenton, M., Leitner, M., & Wood, J. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001943 · Cited by 162
Mirtazapine versus other antidepressive agents for depression
Watanabe, N., Omori, I. M., Nakagawa, A., Cipriani, A., Barbui, C., Churchill, R. C., & Furukawa, T. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006528.pub2 · Cited by 166
Haloperidol versus placebo for schizophrenia
Adams, C. E., Bergman, H., Irving, C. B., & Lawrie, S. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003082.pub3 · Cited by 157
Gillies, D. M., Sinn, J. K. H., Lad, S. S., Leach, M., & Ross, M. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007986.pub2 · Cited by 173
Antidepressants for the treatment of depression in people with cancer
Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., & Hotopf, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub3 · Cited by 158
Community mental health team management in severe mental illness: A systematic review
Simmonds, S., Coid, J., Joseph, P. L. A., Marriott, S., & Petertyrer (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.6.497 · Cited by 155
Does the Addition of a Second Antipsychotic Drug Improve Clozapine Treatment?
Barbui, C., Signoretti, A., Mule, S., Boso, M., & Cipriani, A. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn030 · Cited by 153
Gillies, D. M., Taylor, F., Gray, C., O’Brien, L., & D’Abrew, N. (2013) · Evidence-Based Child Health A Cochrane Review Journal · doi:10.1002/ebch.1916 · Cited by 177
Aripiprazole versus other atypical antipsychotics for schizophrenia
Khanna, P., Suo, T., Komossa, K., Ma, H., Rummel-Kluge, C., El-Sayeh, H. G., Leucht, S., & Xia, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006569.pub5 · Cited by 151
Containment strategies for people with serious mental illness
Muralidharan, S., & Fenton, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002084.pub2 · Cited by 153
Cipriani, A., Williams, T., Nikolakopoulou, A., Salanti, G., Chaimani, A., Ipser, J., Cowen, P. J., Geddes, J. R., & Stein, D. J. (2017) · Psychological Medicine · doi:10.1017/s003329171700349x · Cited by 155
“Data synthesis and statistical analysis For continuous outcome, where different measures were used to assess the same outcome, standardised mean difference (SMD) (Hedges’s adjusted g) were used (Altman & Bland, 1996; Higgins & Green, 2011).”
MethodMusic therapy for schizophrenia or schizophrenia-like illnesses
Gold, C., Heldal, T. O., Dahle, T., & Wigram, T. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004025.pub2 · Cited by 153
Van Dessel, N., Den Boeft, M., van der Wouden, J. C., Kleinstäuber, M., Leone, S. S., Terluin, B., Numans, M. E., van der Horst, H. E., & van Marwijk, H. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011142 · Cited by 148
Tissue adhesives for traumatic lacerations in children and adults
Farion, K. J., Russell, K. F., Osmond, M. H., Hartling, L., Klassen, T. P., Durec, T., & Vandermeer, B. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003326 · Cited by 148
Pharmacological interventions for those who have sexually offended or are at risk of offending
Khan, O., Ferriter, M., Huband, N., Powney, M. J., Dennis, J. A., & Duggan, C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007989.pub2 · Cited by 144
Assertive community treatment for people with severe mental disorders
Marshall, M., & Lockwood, A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001089.pub2 · Cited by 146
RetractedRecommendations for accurate reporting in medical research statistics
Mansournia, M. A., & Nazemipour, M. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00139-9 · Cited by 146
Azapirones for generalized anxiety disorder
Chessick, C. A., Allen, M. H., Thase, M. E., Batista Miralha da Cunha, A. A., Kapczinski, F., Silva de Lima, M., & dos Santos Souza, J. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006115 · Cited by 144
Melnik, T., Hawton, K. E., & McGuire, H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001760.pub2 · Cited by 150
Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia
Barber, S., Olotu, U., Corsi, M., & Cipriani, A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006324.pub3 · Cited by 144
Pompoli, A., Furukawa, T. A., Imai, H., Tajika, A., Efthimiou, O., & Salanti, G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011004.pub2 · Cited by 142
Pharmacological interventions for people with borderline personality disorder
Binks, C., Fenton, M., McCarthy, L., Lee, T., Adams, C. E., & Duggan, C. F. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005653 · Cited by 142
Gauze and tape and transparent polyurethane dressings for central venous catheters
Webster, J., Gillies, D. M., O'Riordan, E., Sherriff, K. L., & Rickard, C. M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003827.pub2 · Cited by 141
RetractedPolyunsaturated fatty acid supplementation for schizophrenia
Irving, C. B., Mumby-Croft, R., & Joy, L. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001257.pub2 · Cited by 140
Thabrew, H., Stasiak, K., Hetrick, S. E., Wong, S., Huss, J. H., & Merry, S. N. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012489.pub2 · Cited by 141
“Altman 1996 Altman DG, Bland JM. Detecting skewness from summary information.”
BackgroundMethodInfluentialPsychological therapies for people with borderline personality disorder
Binks, C., Fenton, M., McCarthy, L., Lee, T., Adams, C. E., & Duggan, C. F. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005652 · Cited by 145
Day hospital versus admission for acute psychiatric disorders
Marshall, M., Crowther, R., Sledge, W. H., Rathbone, J., & Soares-Weiser, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004026.pub2 · Cited by 137
Psychoeducation (brief) for people with serious mental illness
Zhao, S., Sampson, S. J., Xia, J., & Jayaram, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010823.pub2 · Cited by 157
Psychosocial interventions for conversion disorder
Ruddy, R., & House, A. O. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005331.pub2 · Cited by 138
Exercise therapy for schizophrenia
Gorczynski, P. F., & Faulkner, G. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004412.pub2 · Cited by 138
Haloperidol plus promethazine for psychosis-induced aggression
Huf, G., Alexander, J., Gandhi, P., & Allen, M. H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005146.pub3 · Cited by 134
Vitamin E for neuroleptic-induced tardive dyskinesia
Soares‐Weiser, K., Maayan, N., & McGrath, J. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000209.pub2 · Cited by 134
Atkinson, G., & Batterham, A. M. (2013) · Vascular Medicine · doi:10.1177/1358863x13508446 · Cited by 133
Psychosocial treatment programmes for people with both severe mental illness and substance misuse
Jeffery, D., Ley, A., McLaren, S., & Siegfried, N. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001088 · Cited by 133
Compulsory community and involuntary outpatient treatment for people with severe mental disorders
Kisely, S. R., Campbell, L. A., & Preston, N. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004408.pub3 · Cited by 135
Clozapine versus typical neuroleptic medication for schizophrenia
Wahlbeck, K., Cheine, M. V., & Essali, A. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000059 · Cited by 136
Nakama, G. Y., Peccin, M. S., Almeida, G. J., Neto, O. D. A. L., de Queiroz, A. A. B., & Navarro, R. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006193.pub2 · Cited by 130
Fluoxetine versus other types of pharmacotherapy for depression
Cipriani, A., Brambilla, P., Furukawa, T. A., Geddes, J. R., Gregis, M., Hotopf, M. H., Malvini, L., & Barbui, C. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185.pub2 · Cited by 146
Valproate for acute mood episodes in bipolar disorder
Macritchie, K., Geddes, J. R., Scott, J. L., Haslam, D. R. S., de Lima, M. S., & Goodwin, G. M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004052 · Cited by 129
Mind and body therapy for fibromyalgia
Theadom, A., Cropley, M., Smith, H. E., Feigin, V. L., & McPherson, K. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001980.pub3 · Cited by 151
Art therapy for schizophrenia or schizophrenia-like illnesses
Ruddy, R., & Milnes, D. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003728.pub2 · Cited by 127
Psychosocial interventions for people with both severe mental illness and substance misuse
Cleary, M. L., Hunt, G. E., Matheson, S. L., Siegfried, N., & Walter, G. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001088.pub2 · Cited by 130
Meditation therapies for attention-deficit/hyperactivity disorder (ADHD)
Krisanaprakornkit, T., Ngamjarus, C., Witoonchart, C., & Piyavhatkul, N. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006507.pub2 · Cited by 132
Perioperative buffered versus non-buffered fluid administration for surgery in adults
Burdett, E., Dushianthan, A., Bennett‐Guerrero, E., Cro, S., Gan, T. J., Grocott, M. P. W., James, M. F., Mythen, M. G., O’Malley, C., Roche, A. M., et al. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004089.pub2 · Cited by 128
Ostuzzi, G., Bertolini, F., Tedeschi, F., Vita, G., Brambilla, P., Fabro, L. D., Gastaldon, C., Papola, D., Purgato, M., Nosari, G., et al. (2022) · World Psychiatry · doi:10.1002/wps.20972 · Cited by 136
Srisurapanont, M., Maneeton, B., Maneeton, N., Lankappa, S. T., & Gandhi, R. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000967.pub2 · Cited by 124
Compulsory community and involuntary outpatient treatment for people with severe mental disorders.
Kisely, S. R., Campbell, L. A., & O'Reilly, R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004408.pub5 · Cited by 123
Dressings and topical agents for preventing pressure ulcers
Moore, Z. E. H., & Webster, J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009362.pub2 · Cited by 122
Barbui, C., Furukawa, T. A., & Cipriani, A. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.070693 · Cited by 120
Psychosocial interventions for people with both severe mental illness and substance misuse
Hunt, G. E., Siegfried, N., Morley, K. C., Sitharthan, T., & Cleary, M. L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001088.pub3 · Cited by 125
Pharmacotherapies for sleep disturbances in Alzheimer's disease
McCleery, J. M., Cohen, D. A., & Sharpley, A. L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009178.pub2 · Cited by 116
Jones, R. M., Arlidge, J., Gillham, R., Reagu, S. M., van den Bree, M. B. M., & Taylor, P. J. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.083030 · Cited by 115
Risperidone versus other atypical antipsychotics for schizophrenia
Komossa, K., Rummel‐Kluge, C., Schwarz, S., Schmid, F., Hunger, H., Kissling, W., & Leucht, S. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006626.pub2 · Cited by 119
Antiepileptics for aggression and associated impulsivity
Huband, N., Ferriter, M., Nathan, R., & Jones, H. G. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003499.pub3 · Cited by 114
WHY ARE PHARMACOKINETIC DATA SUMMARIZED BY ARITHMETIC MEANS?
Julious, S. A., & Debarnot, C. A. M. (2000) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-100101013 · Cited by 113
Surgical intervention for anorectal fistula
Jacob, T. J. K., Perakath, B., & Keighley, M. R. B. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006319.pub2 · Cited by 113
Advance treatment directives for people with severe mental illness
Campbell, L. A., & Kisely, S. R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005963.pub2 · Cited by 112
Cipriani, A., Saunders, K., Attenburrow, M.-J., Stefaniak, J. D., Panchal, P., Stockton, S., Lane, T. A., Tunbridge, E. M., Geddes, J. R., & Harrison, P. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.86 · Cited by 111
Injected corticosteroids for treating plantar heel pain in adults
David, J. A., Sankarapandian, V., Christopher, P. R., Chatterjee, A., & Macaden, A. S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009348.pub2 · Cited by 110
Chlorpromazine Dose for People With Schizophrenia
de Haan, S., & Liu, X. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp014 · Cited by 109
Length of hospitalisation for people with severe mental illness
Babalola, O., Görmez, V., Alwan, N. A., Johnstone, P. W., & Sampson, S. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000384.pub3 · Cited by 112
Antidepressants plus benzodiazepines for adults with major depression
Ogawa, Y., Takeshima, N., Hayasaka, Y., Tajika, A., Watanabe, N., Streiner, D. L., & Furukawa, T. A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001026.pub2 · Cited by 117
“…scores and study authors were unable to provide standard deviations, we calculated the standard deviation from the standard error (SE) or P values (Altman 1996), or from CI, t-values or P values as described in Section 7.7.3 of the Cochrane Handbook for Systematic Reviews of Interventions…”
BackgroundMethodInfluentialBenzodiazepines for psychosis-induced aggression or agitation
Zaman, H., Sampson, S. J., Beck, A., Sharma, T., Clay, F. J., Spyridi, S., Zhao, S., & Gillies, D. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003079.pub4 · Cited by 112
Collaborative care approaches for people with severe mental illness
Reilly, S., Planner, C., Gask, L., Hann, M., Knowles, S. E., Druss, B. G., & Lester, H. E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009531.pub2 · Cited by 116
Electroconvulsive therapy for treatment-resistant schizophrenia
Sinclair, D. J., Zhao, S., Qi, F., Nyakyoma, K., Kwong, J. S., & Adams, C. E. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011847.pub2 · Cited by 114
Glutamatergic drugs for schizophrenia
Tiihonen, J., & Wahlbeck, K. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003730.pub2 · Cited by 108
Psychosocial interventions for people with both severe mental illness and substance misuse
Hunt, G. E., Siegfried, N., Morley, K., Brooke-Sumner, C., & Cleary, M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001088.pub4 · Cited by 105
Tuunainen, A., Wahlbeck, K., & Gilbody, S. M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00212-2 · Cited by 104
Interventions for prodromal stage of psychosis
Kuharić, D. B., Kekin, I., Hew, J., Kuzman, M. R., & Puljak, L. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012236.pub2 · Cited by 116
Psychological interventions for antisocial personality disorder
Gibbon, S., Khalifa, N. R., Cheung, N. H.-Y., Vӧllm, B., & McCarthy, L. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007668.pub3 · Cited by 124
“We define skewness as occurring when, for a scale or measure with positive values and a minimum value of zero, the mean is less than twice the standard deviation (Altman 1996).”
BackgroundEffects of treatment with metformin on TSH levels: a meta-analysis of literature studies
Lupoli, R., Di Minno, A., Tortora, A., Ambrosino, P., Arianna Lupoli, G., & Di Minno, M. N. D. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2965 · Cited by 102
Residential alternatives to acute psychiatric hospital admission: systematic review
Lloyd-Evans, B., Slade, M., Jagielska, D., & Johnson, S. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.058347 · Cited by 94
S-adenosyl methionine (SAMe) for depression in adults
Galizia, I., Oldani, L., Macritchie, K., Amari, E., Dougall, D., Jones, T. N., Lam, R. W. M., Massei, G. J., Yatham, L. N., & Young, A. H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011286.pub2 · Cited by 109
Antioxidant treatments for schizophrenia
Magalhães, P. V. D. S., Dean, O. M., Andreazza, A. C., Berk, M., & Kapczinski, F. P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008919.pub2 · Cited by 106
Dias, J. F., Oliveira, V. C., Borges, P. R. T., Dutra, F. C. M. S. E., Mancini, M. C., Kirkwood, R. N., Resende, R. A., & Sampaio, R. F. (2020) · British Journal of Sports Medicine · doi:10.1136/bjsports-2019-101375 · Cited by 102
Mukundan, A., Faulkner, G., Cohn, T. A., & Remington, G. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006629.pub2 · Cited by 103
Metadata
- Authors
- Altman, D. G., & Bland, J. M.
- Affiliations
- University of Oxford (GB)
- ORCID
- Altman, Douglas G
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1996-11-09
- Volume
- 313
- Issue
- 7066
- Pages
- 1200.1
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- PMC
- PMC2352469
- OpenAlex
- W1591259115
- Cited by
- 1,278
- References
- 4
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 26 · 2023: 24 · 2022: 31 · 2021: 33 · 2020: 43 · 2019: 48 · 2018: 54 · 2017: 65 · 2016: 70 · 2015: 72 · 2014: 79 · 2013: 70 · 2012: 87
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)
- Locations
- BMJ (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Keywords
- airway resistance, interrupter technique, coefficient of variation, bronchodilator responsiveness, salbutamol, pediatric respiratory symptoms, measurement standardization, skewness
- MeSH terms
- Analysis of Variance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review